XML 54 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Net income $ 75,020,000 $ 54,084,000 $ 24,806,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 10,607,000 10,790,000 10,398,000
Non-cash stock-based expense 3,183,000 2,704,000 3,642,000
Non-cash portion of restructuring and impairment charges 0 0 100,000
Loss on extinguishment of debt 1,217,000 0 18,573,000
Gain (loss) on sale of assets (43,000) 74,000 127,000
Deferred income taxes 9,366,000 (1,757,000) (110,183,000)
Deferred income taxes   1,225,000  
Gain on sale of townhomes (3,843,000) 0 0
Provision for loss on mortgage receivable 0 0 5,000,000
Provision for loss on non-consolidated real estate businesses 0 0 3,500,000
Gain on liquidation of long-term investments accounted for at cost (25,832,000) 0 0
(Income) loss on long-term investments accounted under the equity method 859,000 (2,604,000) 0
Gain on sale of marketable securities (23,257,000) (19,869,000) 0
Equity income in non-consolidated real estate businesses (19,966,000) (23,963,000) (15,213,000)
Distributions from non-consolidated real estate businesses 9,322,000 12,212,000 6,466,000
Premium of issuance of debt 0 3,450,000 0
Non-cash interest expense 7,373,000 1,082,000 51,209,000
Gain on warrants (700,000) 0 0
Changes in assets and liabilities:      
Receivables (23,020,000) 6,249,000 1,408,000
Inventories (2,149,000) (8,593,000) (5,905,000)
Accounts payable and accrued liabilities (3,216,000) 2,575,000 (6,618,000)
Payments due under the Master Settlement Agreement 26,419,000 32,985,000 10,653,000
Cash payments on restructuring liabilities 0 (179,000) (902,000)
Other assets and liabilities, net (5,299,000) (5,218,000) 8,606,000
Net cash provided by operating activities 36,041,000 67,004,000 5,667,000
Cash flows from investing activities:      
Proceeds from sale or maturity of investment securities 31,643,000 28,587,000 78,000
Purchase of investment securities (5,039,000) (9,394,000) (12,427,000)
Proceeds from sale or liquidation of long-term investments 66,190,000 1,002,000 2,254,000
Purchase of long-term investments (10,000,000) (5,062,000) (51,000)
Purchase of Aberdeen mortgages 0 (13,462,000) 0
Proceeds from sale of townhome, net 19,629,000 0 0
Decrease (increase) in restricted assets (96,000) (1,100,000) 1,720,000
Investments in non-consolidated real estate businesses (41,859,000) (24,645,000) (474,000)
Distributions from non-consolidated real estate businesses 8,450,000 3,539,000 6,730,000
Issuance of notes receivable (15,256,000) (930,000) 0
Cash acquired in Aberdeen consolidation 0 473,000 0
Proceeds from sale of businesses and assets 205,000 187,000 41,000
Capital expenditures (11,838,000) (23,391,000) (3,848,000)
Increase in cash surrender value of life insurance policies (744,000) (936,000) (839,000)
Net cash provided by (used in) investing activities 41,285,000 (45,132,000) (6,816,000)
Cash flows from financing activities:      
Proceeds from issuance of debt 6,419,000 185,714,000 118,805,000
Repayments of debt (4,960,000) (14,539,000) (6,179,000)
Deferred financing costs 0 (5,077,000) (5,573,000)
Borrowings under revolver 1,064,270,000 1,034,924,000 749,474,000
Repayments on revolver (1,078,508,000) (1,016,598,000) (751,607,000)
Distributions on common stock (125,299,000) (117,459,000) (115,778,000)
Proceeds from exercise of Vector options 1,029,000 1,265,000 1,194,000
Tax benefit of options exercised 821,000 269,000 9,162,000
Net cash (used in) provided by financing activities (136,228,000) 68,499,000 (502,000)
Net increase (decrease) in cash and cash equivalents (58,902,000) 90,371,000 (1,651,000)
Cash and cash equivalents, beginning of year 299,825,000 209,454,000 211,105,000
Cash and cash equivalents, end of year $ 240,923,000 $ 299,825,000 $ 209,454,000